Interestingly, there was a significant increase in Lpcat2 (4‐fold) and cPla2 (3‐fold) for the mice that developed NASH (32‐week WD), whereas no change in Alox15 was observed across groups (Fig. 7C). The gene discussed is ALOX15; the disease is metabolic dysfunction-associated steatohepatitis.